Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000011

Chief Legal Officer gave up 2,155 shares (to pay taxes)

  • Chief Legal Officer acquired 6,988 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-14 Exercise or conversion : show line 1 in the form +1,738 11,189 D
2022-02-14 Exercise or conversion : show line 2 in the form +5,250 16,439 D
2022-02-14 Shares withheld for taxes : show line 3 in the form −2,155 $30.50 $65,728 14,284 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-14 Exercise or conversion : show line 4 in the form Restricted stock units −1,738 1,738 D
2022-02-14 Exercise or conversion : show line 5 in the form Restricted stock units −5,250 0 D
Loading xslF345X03/wf-form4_164504886293133.xml…